Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
(Q28248186)
scientific article
scientific article
Language:
Current Data About
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
| (P31) |
(Q13442814)
|
||||||||||||
| (P304) |
3706-12
|
||||||||||||
| (P407) |
(Q1860)
|
||||||||||||
| (P433) |
16
|
||||||||||||
| (P478) |
23
|
||||||||||||
| (P577) |
Wednesday, June 1, 2005
|
||||||||||||
| (P921) |
(Q181600)
(Q188874)
(Q413299)
(Q108566365)
(Q25493920)
|
||||||||||||
| (P1433) |
(Q400292)
|
||||||||||||
| (P1476) |
"Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer" (language: en)
|
||||||||||||
| (P2093) |
Fairooz F Kabbinavar
Julie Hambleton
Robert D Mass
Herbert I Hurwitz
Emily Bergsland
Somnath Sarkar
|